Breaking News on Supplements & Nutrition - North AmericaEU edition

Products > Clinical Study

AmealPeptide Overview & Studies

Published: 23-Jan-2013 | Format: PDF file | Document type: Clinical Study

AmealPeptide®: Clinically Proven to Maintain Blood Pressure Levels Already within Normal Range*
 
Maintaining blood pressure within healthy limits and promoting arterial flexibility are key strategies for enhancing cardiovascular health. AmealPeptide® is a clinically proven fermented milk protein that does both.* Supported by a dozen placebo-controlled human clinical trials, AmealPeptide® has been shown to maintain both systolic and diastolic blood pressure already within healthy limits and to encourage arterial flexibility.*
 
AmealPeptide® is produced through a proprietary fermentation and enzymatic process that releases two tripeptides, VPP and IPP. These tripeptides work by inhibiting an enzyme that constricts the blood vessels, thus promoting normal blood circulation.* AmealPeptide® has FDA-notified GRAS status.
 
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Supplier's Info Centre

Maypro

Fill Form to Download Now!

*
*
*
*
*
*
*
*

Please note that any information that you supply is protected by our Privacy and Cookie Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.